Ellevest Inc’s Rentokil RTO Stock Holding History

Ellevest Inc’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,158	Closed	-$42.3K	–	1364
2023 Q1	$42.3K	Hold	1,158	–	–	﹤0.01%	642
2022 Q4	$35.7K	Buy	+1,158	New	+$35.9K	﹤0.01%	703

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MNG

Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ellevest Inc's RTO Position: Q2 2023 in Review

Ellevest Inc sold out of Rentokil (RTO) in Q2 2023, closing a stake of 1,158 shares — an estimated $42.3K sold.

Ellevest Inc first reported a position in RTO in Q4 2022 and held it in 2 quarters. The position peaked at $42.3K in Q1 2023. 199 funds tracked by Wall St. Rank hold RTO as of Q2 2023.

Ellevest Inc reported no remaining Rentokil position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 1,158 Rentokil shares in Q2 2023, an estimated $42.3K.
Ellevest Inc first reported a position in Rentokil in Q4 2022 and held it in 2 quarters.
Ellevest Inc's Rentokil position peaked at $42.3K in Q1 2023.
199 funds tracked by Wall St. Rank held Rentokil as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.